Chloroform

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Chloroform
Accession Number
DB11387
Type
Small Molecule
Groups
Approved, Vet approved
Description

Chloroform is an organic small molecule, member of the family of the chloromethanes that presents a formula of CHCl3. It is a colorless, sweet-smelling, dense liquid that is produced on a large scale as a precursor to PTFE and refrigerants, but the latter application is declining.

Structure
Thumb
Synonyms
  • 1,1,1-trichloromethane
  • CHCl3
  • Chloroforme
  • chloroformium pro narcosi
  • Trichlormethan
  • Trichloromethane
  • trichlorométhane
External IDs
NSC-77361
Categories
UNII
7V31YC746X
CAS number
67-66-3
Weight
Average: 119.378
Monoisotopic: 117.914383153
Chemical Formula
CHCl3
InChI Key
HEDRZPFGACZZDS-UHFFFAOYSA-N
InChI
InChI=1S/CHCl3/c2-1(3)4/h1H
IUPAC Name
trichloromethane
SMILES
ClC(Cl)Cl

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
AbemaciclibThe serum concentration of Abemaciclib can be increased when it is combined with Chloroform.
AcebutololThe serum concentration of Acebutolol can be increased when it is combined with Chloroform.
AcetaminophenThe serum concentration of Acetaminophen can be increased when it is combined with Chloroform.
AcetyldigoxinChloroform may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
Acetylsalicylic acidThe serum concentration of Acetylsalicylic acid can be increased when it is combined with Chloroform.
AdinazolamThe therapeutic efficacy of Chloroform can be increased when used in combination with Adinazolam.
AfatinibThe serum concentration of Afatinib can be increased when it is combined with Chloroform.
AldosteroneThe serum concentration of Aldosterone can be increased when it is combined with Chloroform.
AlfaxaloneThe therapeutic efficacy of Chloroform can be increased when used in combination with Alfaxalone.
AlfentanilThe therapeutic efficacy of Chloroform can be increased when used in combination with Alfentanil.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
  1. FEATHERSTONE HW: Chloroform. Anesthesiology. 1947 Jul;8(4):362-71. [PubMed:20255057]
  2. PAYNE JP: Chloroform. Med Illus. 1955 Oct;9(10):627-30. [PubMed:13279457]
  3. Authors unspecified: Chloroform. Rep Carcinog. 2002;10:54-6. [PubMed:15320320]
  4. Davison MH: Chloroform. Br J Anaesth. 1965 Sep;37(9):655-60. [PubMed:5320086]
  5. Authors unspecified: Chloroform. Rep Carcinog. 2004;11:III54-6. [PubMed:21089827]
  6. Authors unspecified: Chloroform. IARC Monogr Eval Carcinog Risks Hum. 1999;73:131-82. [PubMed:10804954]
  7. Authors unspecified: Chloroform. Rep Carcinog. 2011;12:97-100. [PubMed:21850127]
  8. Authors unspecified: Chloroform. IARC Monogr Eval Carcinog Risk Chem Hum. 1979 Oct;20:401-27. [PubMed:397171]
  9. Lister J: Chloroform Accidents. Br Med J. 1871 Jul 29;2(552):117-9. [PubMed:20746316]
  10. Prichard A: Chloroform Accidents. Br Med J. 1873 Feb 22;1(634):194-6. [PubMed:20746979]
  11. Firth NL, Ross DA, Thonney ML: Comparison of ether and chloroform for Soxhlet extraction of freeze-dried animal tissues. J Assoc Off Anal Chem. 1985 Nov-Dec;68(6):1228-31. [PubMed:4086448]
  12. Exner T, Papadopoulos G, Sahman N, Koutts J: Solvent extraction of test plasmas for improved recovery of lupus anticoagulant activity. Thromb Haemost. 1990 Aug 13;64(1):121-3. [PubMed:2125754]
  13. Barker JL, Gainer H: Pentobarbital: selective depression of excitatory postsynaptic potentials. Science. 1973 Nov 16;182(4113):720-2. [PubMed:4356518]
  14. Huo Y, Guo C, Zhang QY, Chen WS, Zheng HC, Rahman K, Qin LP: Antinociceptive activity and chemical composition of constituents from Caragana microphylla seeds. Phytomedicine. 2007 Feb;14(2-3):143-6. Epub 2006 May 16. [PubMed:16707255]
  15. Svetaz L, Tapia A, Lopez SN, Furlan RL, Petenatti E, Pioli R, Schmeda-Hirschmann G, Zacchino SA: Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi. J Agric Food Chem. 2004 Jun 2;52(11):3297-300. [PubMed:15161186]
  16. Schmidt CW: Chloroform: An EPA test case. Environ Health Perspect. 1999 Jul;107(7):A358-60. [PubMed:10379014]
  17. Vajrabhaya LO, Suwannawong SK, Kamolroongwarakul R, Pewklieng L: Cytotoxicity evaluation of gutta-percha solvents: Chloroform and GP-Solvent (limonene). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Dec;98(6):756-9. [PubMed:15583552]
  18. Lionte C: Lethal complications after poisoning with chloroform--case report and literature review. Hum Exp Toxicol. 2010 Jul;29(7):615-22. doi: 10.1177/0960327109357142. Epub 2010 Jan 5. [PubMed:20051454]
  19. Cappelletti M, Frascari D, Zannoni D, Fedi S: Microbial degradation of chloroform. Appl Microbiol Biotechnol. 2012 Dec;96(6):1395-409. doi: 10.1007/s00253-012-4494-1. Epub 2012 Oct 24. [PubMed:23093177]
  20. Yang M, Wang L, Xie G, Liu Y: Effects of intermediate metabolites of 37 xenobiotics on the catalytic activities of reconstituted cytochrome P-450IIB1 and P-450IA1 enzyme systems. Biomed Environ Sci. 1993 Mar;6(1):8-26. [PubMed:8476536]
  21. Sprankle CS, Larson JL, Goldsworthy SM, Butterworth BE: Levels of myc, fos, Ha-ras, met and hepatocyte growth factor mRNA during regenerative cell proliferation in female mouse liver and male rat kidney after a cytotoxic dose of chloroform. Cancer Lett. 1996 Mar 19;101(1):97-106. [PubMed:8625290]
  22. Yannai, Shmuel (2003). Dictionary of Food Compounds with : Additives, Flavors, and Ingredients. CRC Press LLC. [ISBN:1584884169]
External Links
Human Metabolome Database
HMDB0029596
KEGG Compound
C13827
ChemSpider
5977
ChEBI
35255
ChEMBL
CHEMBL44618
HET
MCH
Wikipedia
Chloroform
ATC Codes
N01AB02 — Chloroform
PDB Entries
3g4q

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility6.95 mg/mLALOGPS
logP1.67ALOGPS
logP1.83ChemAxon
logS-1.2ALOGPS
Physiological Charge0ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity21.37 m3·mol-1ChemAxon
Polarizability8.52 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - EI-BGC-MSsplash10-001r-9000000000-d2165f9bfa5b3898f4d5
GC-MS Spectrum - EI-BGC-MSsplash10-001r-9000000000-375900f120fe0ebf7c58
GC-MS Spectrum - EI-BGC-MSsplash10-001r-9000000000-4c60f1e48cbdf424460b
Mass Spectrum (Electron Ionization)MSsplash10-001r-9000000000-dd0c3059130b9d8e0a21
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable

Taxonomy

Description
This compound belongs to the class of organic compounds known as trihalomethanes. These are organic compounds in which exactly three of the four hydrogen atoms of methane (CH4) are replaced by halogen atoms.
Kingdom
Organic compounds
Super Class
Organohalogen compounds
Class
Alkyl halides
Sub Class
Halomethanes
Direct Parent
Trihalomethanes
Alternative Parents
Organochlorides / Hydrocarbon derivatives / Alkyl chlorides
Substituents
Trihalomethane / Hydrocarbon derivative / Organochloride / Alkyl chloride / Aliphatic acyclic compound
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
one-carbon compound, chloromethanes (CHEBI:35255) / a small molecule (CPD-843)

Drug created on February 25, 2016 11:19 / Updated on June 04, 2019 07:20